Gilead Sciences (GILD) Financial Analysis & Valuation | Quarter Chart

Gilead Sciences (GILD)

GILD
Price: $126.33
Fair Value: 🔒
🔒score
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla pro... more
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicine... more
Description Shares
Market Cap$156.85BExchangeNASDAQ
SectorHealthcareIndustryDrug Manufacturers - General
CountryUSCEODaniel O'Day
IPO Date1992-01-22CAGR0.33%
Employees17,600Websitewww.gilead.com
Div. Yield2.51%Payout Ratio0.32%
Buy Back Yield0.75%Total Yield3.26%
GILD chart loading...
Fundamentals Technicals
Enterprise Value$160.62BP/E Ratio15.09
Forward P/E13.06PEG Ratio0.31
P/S Ratio5.33P/B Ratio6.73
P/CF Ratio14.66P/FCF Ratio15.29
EPS$8.37EPS Growth 1Y54.53%
EPS Growth 3Y65.69%EPS Growth 5Y3091.3%
Revenue Growth 1Y3.48%Gross Margin0.81%
Operating Margin0.38%Profit Margin0.31%
ROE0.42%ROA0.16%
ROCE0.24%Current Ratio1.87
Quick Ratio1.41Cash Ratio0.8
Debt/Equity0.06Interest Coverage11.29
Altman Z Score4.58Piotroski Score9

View Gilead Sciences financial charts →